Development of hepatic metastasis is responsible for most of colorectal cancer-related deaths. Osteopontin (OPN) is a small integrin-binding N-linked glycoprotein, which plays a crucial role in the formation of hepatic metastasis. This study aimed to suppress Opn expression by an antisense-oligonucleotide (ASO Opn ) to decrease liver metastasis in vivo. administration of the SO resulted in a tumor load reduction, which surprisingly surpassed the ASO Opn effect in vivo in terms of a long-lasting metastasis suppression, which was accompanied with increased survival of the animals. Administration of the ASO Opn in rats was effective in decreasing their liver metastasis. The short-lived effect might be extended by modifications suited to increase the ASOs' half-life. In addition, there was a superior anti-metastatic effect caused by the SO, which has not been reported previously.
Introduction
Colorectal cancer is one of the major causes of cancerrelated deaths in Western countries and ranks third in incidence and mortality worldwide. 1, 2 On the basis of the mesenteric circulation pattern, the liver is the favored target organ for distant colorectal cancer metastasis, followed by the lungs and the peritoneal cavity. 3 As much as 20% of the patients undergoing resection of their primary tumor are diagnosed with synchronous liver metastasis, 4 and the proportion of patients with liver metastasis increases to 50-60% within their subsequent lifetime. 5 Formation of metastasis is a stepwise process, which is mediated by different classes of gene alterations, leading to malignant cell transformation. Recently, three classes of genes have been defined as relevant for metastasis, which include genes for initiation, progression and virulence of the metastatic process. 3 The genes, which are grouped into these hypothetical classes, enhance functions for tumor cell growth and survival, evasion of immune surveillance, angiogenesis, extravasation, invasion, homing and organ-specific tumor cell colonization.
Within the growing group of proteins known to be relevant for organ-specific metastasis, osteopontin (OPN) has been identified as important effector molecule, 6 which belongs to a group of extracellular matrix proteins that have been termed small integrin-binding N-linked glycoproteins. These proteins are important players in cell-cell and cell-matrix communications. 7 Human OPN has a size of 314 amino acids, [8] [9] [10] but is detected in bands with apparent sizes of 41-75 kDa. This is due to different splice variants and intensive post-translational modifications. 11 Specific splice variants have been associated with their expression by breast cancer and are thought to function as supportive for neoplastic growth. 12, 13 In line with this, Opn has been identified as lead marker of colon cancer progression, with the highest mRNA expression levels found in liver metastasis.
OPN has several domains including a conserved thrombin cleavage site (amino acids R168-S169 in human OPN), 8 which splits the protein into two functional fragments. The glycine-arginine-glycine-aspartate-serine (GRGDS) sequence in the N-terminal region contains an arginine-glycine-aspartate binding motif that plays an important role for interaction with various integrins (avb3, ab5, avb1, a4b1, a8b1 and a9b1) and the C-terminal fragment can bind to CD44 splice variants, thus mediating cell adhesion and migration functions. 15, 16 Interaction of OPN with avb3 integrin and CD44 receptors activates signaling pathways, leading to increased metastatic behavior of tumor cells, which include the functions for blocked apoptosis, independent cell proliferation, chemotaxis and motility, and migration and invasion of tumor cells. [17] [18] [19] [20] [21] [22] [23] Interaction of OPN with avb3 integrin also alters the host immunity by increasing cytokine expression 24, 25 and enhances angiogenic functions through avb3-integrinmediated activation of endothelial cells. 7, [26] [27] [28] In view of these important tumor progressive functions, Opn represents a potential therapeutic target for the modulation of tumor progression and metastasis formation. Therefore, it was the aim of this study to silence Opn expression by an antisense-oligomer in CC531 lacZ rat colorectal cancer cells. The effects of Opn silencing were followed in vitro as well as in vivo in a rat liver metastasis model, which was based on the intraportal inoculation of CC531 lacZ cells. By this approach, we wanted to assess the potential of Opn as target in colorectal cancer liver metastasis.
Materials and methods

Cell line and culture conditions
The CC531 lacZ cells were grown in RPMI 1640 medium (Invitrogen, Karlsruhe, Germany) supplemented with 10% fetal calf serum, 2 mM glutamine, streptomycin (100 mg ml
À1
) and penicillin (100 IU ml
). For propagation, 1 Â 10 6 CC531 lacZ cells were transferred into a culture flask (75 cm 2 ) with 20 ml fresh RPMI medium and grown in an incubator (Heraeus Holding, Hanau, Germany) under standard conditions (humidified atmosphere, 37 1C, 5% CO 2 ). The cells were passaged every 4 days to maintain a logarithmic growth.
Oligonucleotides
For downregulation of OPN, an antisense-oligonucleotide (ASO Opn ) was used with the following sequence: 5 0 -TTCATTGGAGTTGCTTGGAA-3 0 (Operon, Ko¨ln, Germany; MW: 6482.14). As controls, the matching sense-oligonucleotide (SO) and a nonsense-oligonucleotide (NSO) were used: SO, 5 0 -TTCCAAGCAACTCC AATGAA-3 0 (Operon; MW: 6358.02) and NSO: 5 0 -GCGAGGGAGTTCTTCTTCTA-3 0 (Operon; MW: 6443.08).
Oligomer transfection CC531 lacZ cells were seeded at a density of 1 Â 10 5 cells per ml medium in six-well plates (Greiner, Frickenhausen, Germany) and incubated for 24 h. By this time, they were 30-50% confluent. Transfection of the CC531 lacZ cells with ASO, SO or NSO was carried out using Lipofectamine 2000 reagent (Invitrogen) in Opti-MEM I medium (Invitrogen). The following concentrations of each oligomer (ASO, SO or NSO) were used: 4, 2 and 1 mg ml À1 with appropriate lipofectamine (LF) volumes according to the manufacturer's recommendation (10, 5 and 2.5%). Reference cells were treated with LF concentrations without oligomers or were not treated at all (blank). CC531 lacZ cells were incubated for 5 h with oligomer-LF complexes to obtain transfection, followed by a 24 h postincubation period.
MTT assay
At 24 h after transfection, CC531 lacZ cells were transferred into 96-well plates (100 ml per well), and following the addition of MTT solution (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide; 10 ml, 10 mg ml À1 ), the cells were incubated for 3 h at 37 1C. Next, the medium was discarded and the cells were lysed by adding 100 ml per well acidified 2-propanol (0.04 N HCl). The formazan crystals, which had been formed in living tumor cells, were carefully dissolved and the absorption was measured at 540 nm (reference filter 690 nm) in an automated microtiter plate spectrophotometer (Anthos Mikrosysteme, Krefeld, Germany). The survival of the treated cells was calculated relative to untreated controls and shown as a concentration-effect curve.
Gene expression pending on cell density The aim of this experiment was to investigate the influence of different cell densities on the expression of Opn in CC531 cells. Therefore, CC531 cells were seeded in a 6-well plate at six different concentrations (5, 10, 15, 20, 25 or 30 Â 10 4 /2 ml per well). After 24 h, the cells were inspected under a microscope and their degree of confluence was monitored. Then, the cells were harvested for subsequent RNA isolation and polymerase chain reaction (PCR) analysis.
RNA isolation and reverse transcription-PCR
For RNA isolation, ASO-and SO-treated CC531 lacZ cells were trypsinized, centrifuged and RNA was isolated according to the instructions of the RNeasy Mini Kit (Qiagen, Hilden, Germany). Briefly, 1 g of homogenized rat liver tissue was lysed in 2 ml G2 lysis buffer (Qiagen) and 1 Â 10 7 CC531 lacZ cells were lysed in RLT buffer (Qiagen). RNA derived from cells and tissues was quantitated spectrophotometrically by a photometer (GeneQuant pro) using the 260/280 ratio and then stored at À21 1C. For cDNA synthesis, a reaction mixture of 100 ng RNA (either from cells or tissue), 2 ml RT buffer (10 Â ), 2 ml dNTP mix (5 mM each), 2 ml oligo-dT primer (1 mM), 1 ml RNAse inhibitor (10 U ml
À1
) and 1 ml Omniscript Reverse Transcriptase (4 U ml
; Qiagen) was incubated in a total volume of 20 ml (diluted in ddH 2 O) at 37 1C for 1 h. The subsequent PCR consisted of 2 ml cDNA reaction mixture, 1 ml MgCl 2 (1.75 mM), 1 ml dNTP mix (200 mM), 2.5 ml buffer (10 Â ), 0.5 ml of each primer and 0.3 ml RedTaq polymerase (Sigma, Taufkirchen, Germany). For amplification of fragments of Opn (NM_012881), the following primer pairs were used: 5 0 -G AGTTTGGCAGCTCAGAGGA-3 0 (left) and 5 0 -TCTGC TTCTGAGATGGGTCA-3 0 (right), resulting in a template of 91 bp as well as 5 0 -CGGTGAAAGTGGCTG AGTTT-3 0 (left) and 5 0 -CAGCATCTGAGTGTTTG CTGT-3 0 (right), resulting in a 66 bp fragment. The reaction mixture was incubated in a thermal cycler (DNA engine, PTC200 Peltier) using the following protocol: initial denaturation at 95 1C for 3 min was followed by 35 cycles of denaturation (0.5 min, 95 1C), annealing (1 min, 72 1C), extension (0.5 min, 72 1C) and a final extension (10 min, 72 1C). Thereafter, the samples were maintained at 4 1C until further use. The amplicons were separated on a polyacrylamide gel (5%) in tris-borate-EDTA buffer at 240 V for 1 h. After electrophoresis, the gel was incubated in ethidium bromide for 15 min, followed by visualization under UV light and documented by videodensitometry (White/UV Transilluminator; Herolab, Wiesloch, Germany).
Protein extraction and western blot
To generate cell lysates of CC531 lacZ cells, 40 ml suspension buffer (100 mM NaCl, 10 mM Tris-HCl (pH ¼ 7.6), 1 mM EDTA (pH ¼ 8.00)), 40 ml lysis buffer (100 mM TrisHCl (pH ¼ 6.8), 200 mM dithiothretiol, 4% sodium dodecylsulfate, 0.2% bromide-phenol blue, 20% glycerol) and protease inhibitor (25 Â , final concentration 4%) was used to lyse 2 Â 10 6 cells. The mixture was vortexed gently and boiled for 5 min at 99 1C, centrifuged at 13 000 r.p.m. at 4 1C for 10 min and the supernatant was transferred to a fresh tube. To generate cell lysates of liver, kidney and testis, 20-40 mg tissue was homogenized in equal amounts of suspension and lysis buffers (see above). The samples were boiled at 99 1C for 10 min and centrifuged at 13 000 r.p.m. at 4 1C for 30 min. After protein determination (BCA protein assay kit; Pierce, Bonn, Germany), a fixed amount of protein (10-40 mg) was mixed with 6 Â loading dye (Fermentas, St Leon-Rot, Germany) and 1 Â dithiothretiol (1:5) solution. Before gel loading, samples were denatured at 99 1C for 10 min. Proteins were separated on 4-12% Bis-Tris gels (NuPAGE; Invitrogen) in sodium dodecylsulfate running buffer (Invitrogen) by electrophoresis (XCell SureLock system; Invitrogen) at 200 V for 1 h. The full range rainbow marker (Amersham Biosciences) was used as size marker. The separated proteins were transferred onto a polyvinylidene difluoride membrane (Hybond; Amersham Biosciences, Freiburg, Germany) in a blotting system filled with transfer buffer (Invitrogen) containing 20% methanol. This membrane was incubated for 2-3 min in Ponceau solution (0.1% Ponceau-S, 5% acetic acid) for unspecific protein detection and loading control, and then washed with ddH 2 O and blocked in blocking solution (5% dry milk in 1 Â Tris base, sodium chloride buffer (TBS) with 0.1% Tween-20 (TBS-T)) for 1 h and incubated with the first antibody in TBS-T with 1% dry milk at 4 1C overnight. Before incubation with the second antibody in TBS-T with 1% dry milk at room temperature for 1.5 h, the membrane was washed four times for 10 min with 0.1% TBS-T. This incubation was followed by washing again four times for 10 min and developing the membrane with ECL (Amersham Biosciences). For reprobing, the membrane was stripped with stripping solution (62.5 mM Tris-HCl, 2% sodium dodecylsulfate, 0.7% b-mercaptoethanol) at 56 1C for 45 min. Then, the membrane was washed and blocked as described before. The following first antibodies (Santa Cruz Technology, Heidelberg, Germany) were used: anti-OPN (p-18, sc-10593; Akm2a1, sc-21742), anti-actin (C-11, sc-1615) and anti-tubulin (sc-8035). Donkey-antigoat (sc-2020; Santa-Cruz) and sheep-anti-mouse (RPN4202; Amersham Biosciences) were used as secondary antibodies.
Animals
For in vivo experiments, male WAG/Rij rats (Charles River, Sulzfeld, Germany) were obtained at an age of 6-7 weeks and a body weight of 120-160 g. They were kept in ventilated racks with Macrolon-III cages (Ventirack; UNO Roestvaststaal, Zevenaar, the Netherlands) under specific pathogen-free conditions. The cages were equipped with a 50-fold exchange of filtered air per hour as well as with a positive air pressure inside. Room conditions were maintained constant during all experiments (temperature 22±1 1C, humidity 50±10%, darklight rhythm 12 h). The animals had free access to a standard laboratory diet and autoclaved water. After an acclimatization period of 7 days, the animals were distributed to experimental groups. All animal experiments were approved by the respective authority (Regierungspra¨sidium, Karlsruhe, Germany). This was in accordance with the national guidelines for animal care and use of laboratory animals.
Treatment with osmotic mini-pumps ASO, SO and NSO were diluted in sterile 0.9% saline solution to yield daily dosages of 4, 2, 1 and 0.25 mg kg À1 . Therapy was administered subcutaneously via osmotic mini-pumps (Alzet, model 2002) with a pumping duration of 14 days and a reservoir volume of 200 ml. Pumps were filled under sterile conditions and stored on ice until subcutaneous implantation in the subscapulary region. The pumps were implanted directly after tumor cell inoculation.
CC531
lacZ cell inoculation CC531 lacZ cells were collected during their logarithmic growth period. Therefore, cells were trypsinized and suspended (4 Â 10 6 cells) in 350 ml PBS À (phosphatebuffered saline without calcium and magnesium ions) and 150 ml Matrigel (Biomatrix EHS solution; Serva, Heidelberg, Germany). The solution was stored on ice until injection. WAG/Rij rats were anesthetized with isoflurane (1.5 vol%) and a median laparotomy was performed. The cecum was exteriorized onto a sterile, saline moistened compress and a mesocolic vein was carefully separated from the mesenteric fat tissue. The tumor cells were injected into this vessel within 60 s under microscopic control using a 28 G needle. After that, the vein was compressed for 1-2 min to prevent bleeding, and the cecum was repositioned into the abdomen. The musculature was sewed with a running suture (4-0 Vicryl; Ethicon, Norderstedt, Germany) and the skin was closed with metal clips. The design of the animal experiments is shown in Table 1 .
b-Galactosidase assay Rats were killed with an overdose of anesthesia. Liver, kidney, testis and blood were collected for subsequent analysis. The wet liver weight was recorded, and the organ was shock frozen and stored at À80 1C until further processing. For quantification of tumor cells, the liver was mashed in lysis buffer (G2; Qiagen; 2 ml g À1 liver tissue) with a Turrax homogenizer (Janke & Kunkel, Staufen, Germany). Homogenized tissue was diluted in lysis buffer (1:10; G2; Qiagen) and centrifuged at 15 000 r.p.m. for 2 min. After that, 2 ml of the supernatant was diluted in 200 ml Galacton-Plus assay buffer (Galacto-Light-Plus b-Galactosidase Reporter gene assay kit; Tropix, Weiterstadt, Germany) and incubated for 60 min at room temperature (25 1C) . A luminometer (Auto Lumat LB 953; EG & G Berthold, Wildbad, Germany) was used to measure the luminescence for 30 min after adding 300 ml accelerator II (provided in the kit). A standard curve was prepared from CC531 lacZ cells grown in vitro. To control for unspecific b-galactosidase activity, a normal liver of a WAG/Rij rat was analyzed in parallel. The b-galactosidase activity was measured immediately after homogenization.
Statistics
The oligomer effects on CC531 lacZ cell proliferation were compared for significant differences with Student's t-test. The relative size of western blot bands was normalized to a housekeeping gene and given as percentage of controls. The effectiveness of oligomer treatment in vivo on tumor load was determined by two non-parametric tests: the Wilcoxon rank-sum test for comparison of two groups, and the Kruskal-Wallis test for comparison of more than two groups. P-values p0.05 were considered significant.
Results
Effect of the ASO
Opn on CC531 lacZ cells growing in vitro The effect of exposing CC531 lacZ cells to an ASO against rat OPN (ASO Opn ) was assessed in comparison to respective SO and NSO controls at RNA and protein levels, as well as on cell proliferation. Figure 1a shows increased Opn mRNA expression in response to all experimental groups. Exposure to the ASO Opn at concentrations of 1, 2 and 4 mg ml À1 resulted in a maximally 3.6-fold increased mRNA level of Opn at the medium concentration (2 mg ml À1 ), whereas the respective SO caused its maximum increase at the lowest concentration (2.9-fold at 1 mg ml À1 ), followed by a steady decline at 2 and 4 mg ml À1 (2.4-and 1.6-fold increased over untreated control). The described mRNA modulation was reflected by corresponding protein levels (Figure 1b) . At 24 h after treatment, the 70 kDa band increased over control for both the ASO Opn and the SO oligomers with rising concentrations. In contrast, the 50 kDa band showed a steady slight decrease (1.8-fold) in response to the ASO Opn , whereas the SO caused a biphasic response with an initial increase (2.0-fold) from the low to the medium concentration, followed by a steep decrease (4.0-fold) at the highest concentration.
Finally, cell proliferation in response to the ASO Opn was also influenced in a biphasic way (Figure 1c) . The lowest ASO Opn concentration caused a slight increase in cell proliferation, followed by a decrease at the higher concentrations; the maximum growth inhibition corresponded to 47% of untreated controls. Interestingly, the SO caused a concentration dependently decreased proliferation to a minimum of 44% of control. The highest concentrations of the ASO and SO caused a significant anti-proliferative effect, respectively (Po0.001). The two lower concentrations of the NSO caused only slight decreases in cell proliferation (85 and 82% of control); the high NSO concentration was associated with a decrease in proliferation to 61% of untreated control.
Correlation between Opn expression and cell confluence in vitro As shown in Figure 2 , after seeding CC531 cells for 24 h, the expression of Opn mRNA detected in these cells increased in parallel to the increasing confluence of tumor cells. CC531 cells, which were seeded at a concentration of 5 or 10 Â 10 4 per well, were 10% and 20% confluent, respectively, and showed no expression of Opn. However the cells, which had a confluence of 40 and 50% corresponding to cell numbers of 15 or 20 Â 10 4 per well, showed a faint 66 bp band of Opn mRNA. Then, the expression of Opn augmented five-and eightfold in CC531 cells corresponding to 70% and 95% cell confluence, respectively. In contrast, the two genes used as control for gene expression (pro-collagen 1a2 and g-tubulin) showed no increased expression with rising cell confluence.
Opn on rats bearing CC531 lacZ cells in vivo As demonstrated by animal weights, there was no discernable toxicity in response to the ASO oligomer. The results of treating WAG/Rij rats implanted with CC531 lacZ cells are shown in Figure 3 . Normal, untreated tissues (kidney and testis) showed a single OPN band at an apparent size of 70 kDa. This band showed a linear reduction to a minimum of less than 50% in response to 1, 2 and 4 mg kg À1 ASO
Opn
, administered continuously to rats over 2 weeks (Figure 3a) . Different from kidney and testis, plasma of untreated and ASO Opn -treated control rats showed three bands that were recognized by the OPN antibody with apparent sizes of 70, 50 and 28 kDa (Figure 3b ). Untreated tumor-bearing rats did not show the 70 kDa band, but upon ASO Opn treatment, this band re-appeared. Liver tissue of untreated or ASO Opn -treated non-tumor-bearing rats showed a main OPN band with an apparent size of 70 kDa and two faint bands at 50 and 28 kDa (Figure 3c, lane 2) . Tumor-bearing rats showed three distinct bands, corresponding to 70, 50 and 28 kDa. The Opn expression of CC531 lacZ cells cultivated in vitro is not visible in order to avoid overexposure of the corresponding bands from in vivo experiments (Figure 3c, lane 1) . From this difference in expression intensity, we estimate that the in vivo expression of OPN in CC531 lacZ cells was more than 30.0-fold higher than in CC531 lacZ cells grown in vitro.
ASO
Opn treatment was associated with a reduction of the two lower bands, whereas the 70 kDa band increased up to 2.9-fold at a dosage of 2 mg kg À1 ASO Opn (Figure 3d ). The corresponding evaluation of tumor cell counts in rat liver after 14 days showed a dose dependent, but not significant (P ¼ 0.097) decrease in tumor cell number (Table 1a ). The highest dosage was associated with a T/C % value of 11.2, corresponding to 488% tumor growth inhibition (Figures 4a and b) . However, 1 week after cessation of ASO Opn exposure, the tumor load of treated animals was at least as high as that of controls, indicating a quick loss of anti-metastatic activity (Table 1b) .
Effect of the SO on rats bearing CC531 lacZ cells in vivo As observed for the ASO, administration of the SO caused no discernable toxicity as assessed by the body weight of the animals. Rats treated with the senseoligomer for a period of 14 days showed a therapeutic effect ranging from ineffective (0.25 mg kg
À1
) to significantly active (4 mg kg
; Table 1b ). The reduction in tumor load was clearly dose dependent and lasted for at least 1 week after cessation of the SO administration. Rats treated with the highest SO dosage (4 mg kg À1 ) over a period of 4 weeks showed a twofold increase in survival time (6 weeks) with no appearance of tumor symptoms, except one little tumor nodule (Figure 4c) . In an attempt to correlate the treatment effects with Opn expression, the following picture emerged ( Figure 5 ): normal liver showed a main band, corresponding to 70 kDa and a faint band at 28 kDa size (lane 1). The Opn expression in lysates of CC531 lacZ cells grown in vitro was below the detection limit (lane 2). Lysates from CC531 lacZ cell that infiltrated the liver tissue showed an additional 50 kDa band (lanes 4-9). Administration of the SO to tumor-bearing rats caused a reduction or disappearance of this 50 kDa band, and also, to a lesser degree, of the 28 kDa band. In contrast, the 70 kDa band increased up to threefold in response to the most intensive SO treatment.
Discussion
OPN is highly expressed by CC531
lacZ colorectal cancer cells growing in rat liver, but as shown before, its expression is markedly decreased upon explantation of these tumor cells and subsequent culture in vitro. 29 To follow this phenomenon, the dependence of Opn expression from cell culture conditions was investigated. Clearly, the confluence of cells was related to their Opn expression. Also, exposure to LF induced Opn mRNA expression and this increased level was then reduced by the presence of the oligomers. Remarkably, the effect of the ASO Opn on Opn expression was less prominent than that of the SO. Increased gene expression in response to LF has been observed by other authors as well. 30 An even more intensive induction of Opn expression was caused upon implantation of CC531 lacZ cells into the rat liver (Figure 3c, lane 3) . We therefore hypothesized that silencing of Opn would result in an anti-metastatic effect. Indeed, there was a clear reduction in Opn expression, but this reduction differed between the two and three OPN bands detected by the antibody. Healthy tissues showed a clear 70 kDa band, but weak signals if any at 50 and 28 kDa. Plasma of healthy rats however showed distinct 50 and 28 kDa bands besides the 70 kDa band, indicating a processing of the largest band into breakdown products. Remarkably, liver tissue infiltrated with CC531 lacZ cells was characterized by intense 50 and 28 kDa bands (Figure 3c, lane 3) , which on successful treatment were reduced or even disappeared. This indicates that the two smaller protein bands detected by the OPN antibody could be tumor-specific forms of OPN supporting tumor growth. The existence of tumor-specific Opn forms has already been reported for breast cancer. 12, 13 The assumption that the smaller Opn bands are instrumental for cancer growth is supported by the observation that a 28 kDa fragment of rat OPN, which resulted from the digestion of OPN by endoproteinase Arg-C, was active in cell attachment via a non-RGD sequence. 31 After 2 weeks, the treatment induced reduction in Opn expression corresponded to a 488% decreased tumor load in response to the maximum ASO Opn dosage. However, the nonsignificant anti-neoplastic effect of the ASO Opn was short lived as indicated by the tumor load measured 1 week after treatment cessation. This observation suggests that a more successful treatment probably requires a prolonged administration of the ASO Opn , or chemical modifications suited to increase the half-life of the oligomer. General physiological barriers inhibiting a sufficient activity of single-stranded oligomers include a rapid renal clearance, a tight endothelial cell barrier, oligomer degradation by plasma nuclease activity and clearance by immune cells, such as circulating monocytes and tissue macrophages. 32 Several chemical modifications have been developed over the past years for oligomers to deal with these barriers. The most common stabilizing modification against nucleases is the substitution of a sulfur atom for a non-bridging phosphate oxygen atom, as was used for the ASO Opn . The short-lived ASO Opn effect in this study may be improved by suited oligonucleotide chemistries such as 2 0 -OH modifications, or the use of locked or peptide nucleic acids. 32, 33 In variance to the ASO Opn , its complementary senseoligomer showed an unexpected antitumor effect. The anti-proliferative effect of the SO in vitro was only marginally better, but surpassed that of the ASO Opn significantly in vivo. When comparing the two treatment groups, the duration of the SO antitumor effect was distinctly more sustained than that of the ASO Opn , as shown by a 75% reduction in tumor load at 1 week after the end of administering the highest SO dose (4 mg kg
À1
). When the duration of the SO treatment was continued for periods longer than 2 weeks, the tumor load after 3 weeks treatment was reduced by more than 90% and rats treated over 4 weeks showed an increase in survival time by at least 100%. The phenomenon that a sense control surpasses the effect of the antisense-oligomer cannot be explained yet. Although the reduced Opn expression observed in response to the SO in vitro and in vivo hints to a specific effect, an unspecific mechanism such as a diminished tumor cell number leading to reduced Opn expression cannot be excluded. Despite this lack in confidence, the following facts and considerations may be helpful in understanding the possible mechanism:
The Opn gene is located on chromosome 14 in the rat and on chromosome 4 in the human genome. In rats, there is only one known protein coding transcript for Opn, but there are 11 different splice variants for human Opn, five of which are protein coding transcripts ( Table 2 ). The SO is homolog to a stretch of exon 5 of rat OPN and is located in a highly conserved region ( Figure 6 ). Comparing this region in rat and human Opn, all human splice variants show a 85% identical base and amino-acid sequence to the respective rat gene (Figure 6a ), indicating that this is an important region for OPN function. The same exon harbors an aspartate domain, which is responsible for binding to hydroxyl apatite. Then, there are two sequences ('GRGDS' in both species, 'SVVYGLR' in man and 'SVAYGLR' in rat) that bind À1 bodyweight and ' Â 2' is referred to as using two osmotic mini-pumps sequentially, which implies a continuous SO administration until rats were killed. The overload in lane 2 demonstrates that even under these conditions, no OPN band could be detected in cells grown in vitro. to various integrins (avb3, avb1, avb5, a5b1, a9b1 and a4b1), and there is a thrombin cleavage site adjacent to the possible integrin-binding site (Figure 6b ). 8 A comparison shows that Opn has several functions important for tumor progression and metastasis, which are nearly identical in human and rat Opn.
A search for the SO sequence within the rat genome gave several hits besides OPN (NCBI Blast: Nucleotide sequence), which are characterized by 70-90% similarity to the SO. This implies that the SO could function as antisense oligomer against other, possibly unknown, genes that may modulate regulatory functions in neoplastic growth. This includes the regulation of genes at the post-transcriptional level, for example, by microRNAs (miRNAs), which are known to align to their target mRNA with sequences shorter than 20 nucleotides.
Target-specific binding of miRNA functions through alignment of the first 8 nucleotides of the miRNA stem. 34 In fact, several hits for the first 8 nucleotides of the SO sequence to different genes support the idea that the SO might function as miRNA, even though searching for an miRNA hit with the SO sequence (mirPredict databank for the rat genome; DKFZ, Heidelberg, Germany) did not give a result. Nevertheless, an effect on an unknown miRNA cannot be excluded. 35 Beside these specific effects of the SO function possibly caused by miRNA or antisense-oligomer mechanisms, there is another potential effect of the SO. Short singlestranded DNA sequences (length: 8-30 nt) are able to bind to DNA damage checkpoint and DNA repair proteins, which possess oligonucleotide-oligosaccharidebinding fold domains. The activation of these proteins by short single-stranded DNA are crucial for cell cycle coordination, preserving genomic integrity and control of cell survival. 36 Therefore, activation of genome guardian oligonucleotide-oligosaccharide-binding fold proteins by the SO could possibly lead to decreased tumor cell survival and metastasis reduction.
In conclusion, targeting Opn in vivo by the ASO Opn was not significantly effective in decreasing liver metastasis in rats. The short-lived effect might be extended by modifications suited to increase the ASOs' half-life. In addition, there was a significant and superior antimetastatic effect caused by the sense-oligomer, which has not been reported previously.
